About Current BioData


Current BioData, established by the founders of Swiss-Prot and the Investigational Drugs database (IDdb), combines their unrivaled knowledge and experience of biological data collection, integration and evaluation with expertise drawn from a global network of independent scientific opinion leaders    more



New from Current BioData Ltd - The Target Intelligence Service (TIS)

Current BioData will soon launch a new daily updated service assessing the impact of protein research on drug R&D.The Target Intelligence Service (TIS) is designed to gather, filter and critically evaluate the mass of information published each day about the human proteome to provide intelligence about potential drug targets for the following:

  • Business Development & Licensing Executives
  • Research Portfolio Managers
  • Strategic Planning Executives
  • Competitor Intelligence Practitioners
  • Scientists at all levels engaged in Target Identification and Target Validation

TIS is used to .....

Identify possible partnering opportunities within disparate research groups

View the competitive landscape of early research in molecular and systems biology

Review the evidence available to assess the validity of a potential protein target

Assess commentary from experts on target research that will impact drug R&D

Perform due diligence on 100 days of your science & strategy

 


TIS Exclusive Conference Reports

Current BioData started coverage in 2008 of all the key protein meetings that have a focus on disease and/or drug discovery, providing structured conference reports on the most important new discoveries discussed during the meetings.

The TIS Conference Reporting service will cover approximately 100 biochemistry-oriented conferences each year. The service includes daily overnight reports written "live" by Current BioData staff scientists from major conferences as they happen and specially commissioned Conference Reports by attending scientists, commenting on presentations of particular scientific or commercial interest. In both cases, reports will focus on presentations that further knowledge of the role of proteins in disease and their potential as drug targets.  

List of 2009 conferences covered by the TIS Conference Reporting Service


News from Current BioData

Virtual Academies

"Virtual Academies", made up of experts, have been established to provide opinions and analysis within TIS about the new research on the following groups of protein targets:

Ubiquitin Proteasome System      

The UPS Virtual Academy is headed by Prof. John Mayer.


Lipid Signaling Proteins      

The LS Virtual Academy is headed by Prof. Matthias Wymann.


Epidermal Growth Factor Receptors      

The EGFRs Virtual Academy is headed by Prof. Nancy Hynes.


Epigenetic Regulators      

The ER Virtual Academy is headed by Prof. Steve Baylin.


Kinome      

The Kinome Virtual Academy is headed by Prof. Tony Hunter